Sumatriptan N-Oxide,
212069-94-8,
UNII-1V0XCT6AGU,
1V0XCT6AGU,
GR-112504,
SCHEMBL4135875,
DTXSID00175429,
Sumatriptan Succinate EP impurity D,
ZINC77313237,
GR 112504,
FT-0674781,
Sumatriptan succinate specified impurity D [EP],
A1-03008,
1H-Indole-5-methanesulfonamide, 3-(2-(dimethyloxidoamino)ethyl)-N-methyl-,
3-[2-(Dimethyloxidoamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide,
N,N-Dimethyl-5-(methylsulfamoylmethyl)-1H-indole-3-ethanamine N-oxide,
(3-(2-(Dimethylamino-N-oxide)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide,
N,N-Dimethyl-2-(5-((methylsulfamoyl)methyl)-1H-indol-3-yl)ethanamine N-oxide,
Sumatriptan impurity, (3-(2-(dimethylamino-N-oxide)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide- [USP],
Sumatriptan succinate impurity, (3-(2-(dimethylamino-N-oxide)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide- [USP],
Sumatriptan EP Impurity D,
CS-O-08213,